(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/buy_a_domain.png

Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more

www.crwedomains.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






1299 Result: medical

Crown Equity Holdings Inc., a Vertically Integrated Global Media and Financial Services Company, Announces New Chairman of the Board

June 27th, 2018

Las Vegas, NV / CRWE PRESS RELEASE / June 27, 2018 / Crown Equity Holdings Inc. (OTC PINK: CRWE) is pleased to announce today that Steven A. Cantor has been elected by its Board to serve as Chairman of its Board of Directors. Mr. Cantor will succe. Read more

IBrands Acquires Colorado Real Estate And Shovel-Ready Cannabis Construction Project With Long-Term Tenant

May 09th, 2018

DALLAS, TX / CRWE PRESS RELEASE / May 9, 2018 - iBrands Corporation, Inc. (OTC PINK: IBRC) ("the Company"), a diversified holdings company, announces that it has acquired Durango Warehouse LLC., holder of 38 acres of arable land in Ignacio, Colorado.. Read more

Shire's First Prescription Eye Drop, Xiidra(TM) (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.

August 29th, 2016

Xiidra is the onlyprescription eye drop approved by the U.S. FDA for the treatment of both signs and symptoms of dry eye disease Resources are available to support patients seeking information regarding coverage and savings offers Xiidra is t. Read more

Nymox's New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show

August 29th, 2016

1. Dramatic Decrease in Prostate Cancer and 2. Major Reduction in Need For BPH Prostate Surgery HASBROUCK HEIGHTS, N.J. / CRWE PRESS RELEASE / August 29, 2016 - Nymox Pharmaceutical Corporation (NASDAQ:NYMX) lead drug fexapotide which has been . Read more

New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker

August 28th, 2016

Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS DUBLIN and ROME / CRWE PRESS RELEASE / AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients. Read more

ViewRay's MRIdian System Receives Japanese Regulatory Approval (Shonin)

August 15th, 2016

Expands MRI-Guided Radiation Therapy Access to World’s Third Largest Market CLEVELAND / CRWE PRESS RELEASE / August 15, 2016 – ViewRay, Inc. (Nasdaq: VRAY)announced today that the company received Shonin approval from the Japanese. Read more

Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia

August 02nd, 2016

- CLI is a severe unmet medical need whose treatment addresses a $12 billion global market - Multinational study to be conducted in U.S. and Europe - Estimated trial enrollment of approximately 250 patients - Primary endpoint for BLA will be time . Read more

EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammation and Pain in Cataract Surgery Patients

August 01st, 2016

WALTHAM, Mass. / CRWE PRESS RELEASE / Aug. 01, 2016 — EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing produ. Read more

ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas who have Progressed Following Gemcitabine based Therapy

July 25th, 2016

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall survival (OS) in patients with metastatic pancreatic cancer after previous gemcitabine based therapy Zug, Swit. Read more

Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp

July 20th, 2016

LabCorp’s DNA Testing for Long QT Syndrome, a Congenital Heart Rhythm Disorder Associated with Potentially Lethal Arrhythmias, is Enhanced by TBIO’s Intellectual Property OMAHA, NE / CRWE PRESS RELEASE / July 20, 2016 - Transgenom. Read more

Chronos Therapeutics Acquires Pre-clinical Programmes From Shire

July 20th, 2016

Expands Pipeline With Novel CNS Assets in a Transformative Deal Oxford, UK / CRWE PRESS RELEASE / July 20, 2016 - Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, today. Read more

SWISS Launches Revenue Service with State-of-the-Art Bombardier C Series Aircraft

July 15th, 2016

CS100 aircraft enters service as C Series program gains 127 orders in the first half of 2016 to increase total firm orders to 370 CS300 aircraft on track for first delivery to airBaltic scheduled for the fourth quarter of 2016 M. Read more

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

July 12th, 2016

London, UK / CRWE PRESS RELEASE / July 12, 2016 - GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its propr. Read more

Medtronic to Expand Heart Failure Portfolio with Acquisition of HeartWare International

June 27th, 2016

Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector DUBLIN and FRAMINGHAM, Mass. / CRWE PRESS RELEASE / June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare Internati. Read more

GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex(R) (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome

June 27th, 2016

- Primary endpoint achieved with high statistical significance (p=0.0135) showing that Epidiolex treatment reduces drop seizures compared to placebo – - Today’s LGS data follows successful Phase 3 trial in Dravet syndrome announced in Ma. Read more

Load More Content